The company
Ocugen, Inc.
OCGN · Nasdaq
OCGN stood above a rising 150-day average in 28 of the last 52 weekly readings, and has been out of that trend for the last 24 weeks. It is 44.7% below that average now. Biotechnology: 15% of its 561 stocks in an uptrend (−17 points in four weeks); Health Care: 25% (−11 points in four weeks).
Statistics
- Rotation
- Not moving yet
- Weeks in an uptrend
- out for 24
- Industry in uptrend
- 15% -17 in 4 wk
- Insider buys, 12 months
- $52K
- Insider sales, 12 months
- $1.7M
- Officials’ trades on record
- 2
- Institutions holding
- 144 (+12)
In the rotation
Each square a week: lit when it closed above a rising 150-day average. 28 of 52 weeks.
Biotechnology: Few of its stocks are in an uptrend and the share has fallen sharply over four weeks. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.
Money in and out
Open-market buys above the line and sales below, in dollars.
Congress and officials
2 disclosed lines: House 2, Senate 0, executive 0; 1 people.
| Who | Did | Amount | Traded |
|---|---|---|---|
| Chris Jacobs House: U.S. House ClerkNY27 | sold | $1k–$15k | 8 Nov 2022filed 12 Dec 2022 |
| Chris Jacobs House: U.S. House ClerkNY27 | bought | $15k–$50k | 16 Jun 2022filed 28 Jul 2022 |
Insiders
| Who | Did | Shares | Traded |
|---|---|---|---|
| Shankar MusunuriChief Executive Officer | sold | 468,727at $0.95 | 9 Oct 2026filed 13 Oct 2026 |
| Shankar MusunuriChief Executive Officer | sold | 57,264at $0.95 | 9 Oct 2026filed 13 Oct 2026 |
| Shankar MusunuriChief Executive Officer | sold | 468,727at $1.12 | 9 Sep 2026filed 11 Sep 2026 |
| Shankar MusunuriChief Executive Officer | sold | 57,264at $1.12 | 9 Sep 2026filed 11 Sep 2026 |
| Treerita Essalima Johnson-GreeneChief Financial Officer | bought | 21,000at $1.23 | 15 Jun 2026filed 17 Jun 2026 |
Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.
Institutions
Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.
| Manager | Shares | Change |
|---|---|---|
| BlackRock, Inc.added · filed 7 Aug 2026 | 27,002,933$41.3M | +19,697,954+269.7% |
| STATE STREET CORPadded · filed 7 Aug 2026 | 21,469,307$32.8M | +11,799,116+122.0% |
| VANGUARD CAPITAL MANAGEMENT LLCadded · filed 13 Aug 2026 | 14,372,598$22.0M | +568,487+4.1% |
| MILLENNIUM MANAGEMENT LLCadded · filed 14 Aug 2026 | 13,943,252$21.3M | +216,060+1.6% |
| GEODE CAPITAL MANAGEMENT, LLCadded · filed 12 Aug 2026 | 8,871,013$13.6M | +4,643,909+109.9% |
| RTW INVESTMENTS, LPunchanged · filed 14 Aug 2026 | 6,666,666$10.2M | 00.0% |
| UBS Group AGreduced · filed 13 Aug 2026 | 5,177,508$7.9M | -2,102,812−28.9% |
| Ikarian Capital, LLCunchanged · filed 14 Aug 2026 | 3,962,972$6.1M | 00.0% |
| GMT Capital Corpunchanged · filed 14 Aug 2026 | 3,505,398$5.4M | 00.0% |
| MARSHALL WACE, LLPreduced · filed 13 Aug 2026 | 3,410,257$5.2M | -4,642,093−57.6% |
News
Everyone who traded it
Same industry
Government contracts
No federal award is tied to it.
From its SEC filings
Analyst forecasts
No analyst forecasts yet.